Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Validity and Reliability of the Exergame Enjoyment Questionnaire (EEQ) in Turkish

25. April 2026 aktualisiert von: Gulfidan Tokgoz, Istanbul University - Cerrahpasa

Validity and Reliability of the Exergame Enjoyment Questionnaire (EEQ) in a Geriatric Population in Turkish

The aim of this research is to adapt the Exergame Enjoyment Questionnaire (EEQ) into Turkish and to evaluate its suitability for the Turkish elderly population through validity and reliability analyses. After the cultural adaptation process is completed, the construct validity of the scale will be evaluated using exploratory and confirmatory factor analyses; its reliability will be assessed through internal consistency coefficients (Cronbach's alpha) and test-retest reliability over time (ICC). Accordingly, the study aims to provide a valid and reliable assessment tool for clinicians and researchers who wish to evaluate individual experiences in exergaming-based interventions.

Studienübersicht

Status

Noch keine Rekrutierung

Bedingungen

Detaillierte Beschreibung

While regular exercise plays a critical role in maintaining the physical and cognitive health of the growing elderly population, barriers such as lack of motivation, physical limitations, and boredom restrict participation in exercise among the elderly. Multimodal "exergaming" applications, which combine exercise and gamification dynamics, offer an innovative and enjoyable alternative that enhances the motivation, balance, cognitive skills, and coordination of older individuals. The long-term success of exergaming interventions and the sustainability of participation should be evaluated not only by physical outcomes but also by psychosocial motivational parameters such as enjoyment, flow, and sense of control derived from the game. The Exergame Experience Questionnaire (EEQ) stands out in the literature for measuring this experience. However, the EEQ scale, in its current form, is only valid within the English-speaking cultural context. Despite the increasing prevalence of exergaming applications in Türkiye, the lack of a psychometrically robust and culturally adapted measurement tool capable of evaluating this experience in a multidimensional way hinders the individualization of interventions and the measurement of their effectiveness. This study aims to address this deficiency.

Studientyp

Beobachtungs

Einschreibung (Geschätzt)

46

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienkontakt

Studienorte

      • Balıkesir, Türkei (türkiye)
        • Balıkesir Üniversitesi
        • Kontakt:
        • Unterermittler:
          • Bilal Katipoğlu, Assoc. Prof. Dr.
        • Unterermittler:
          • Nilay ARMAN, Assoc. Prof. Dr.

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

  • Älterer Erwachsener

Akzeptiert gesunde Freiwillige

Ja

Probenahmeverfahren

Nicht-Wahrscheinlichkeitsprobe

Studienpopulation

The study population consists of individuals aged 65 and over residing in the city center of Balıkesir. Accordingly, the sample group will be comprised of volunteer elderly individuals who meet the specified inclusion criteria, have a cognitive capacity suitable for data collection, and have experience with the exergaming applications included in the study protocol.

Beschreibung

Inclusion Criteria:

  • Being 65 years of age or older
  • Having participated in an exergaming application at least once before
  • Not having a physical, sensory or cognitive disability that would prevent participation in the exergaming application
  • Agreeing to participate voluntarily and providing informed consent

Exclusion Criteria:

  1. Individuals with active neurological, vestibular, or psychiatric disorders
  2. Individuals diagnosed with moderate or severe cognitive impairment (MMSE < 24 and/or MoCA < 21)
  3. Individuals with severe hearing or vision loss
  4. Individuals who are physically unable to participate in exergaming due to cardiopulmonary or orthopedic reasons
  5. Individuals with no prior exergaming experience
  6. Individuals who experience significant communication difficulties
  7. Participants who do not sign the voluntary consent form

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

Kohorten und Interventionen

Gruppe / Kohorte
Intervention / Behandlung
Geriartric Indivıduals
The study population consists of individuals aged 65 and over residing in the city center of Balıkesir.
The adaptation process of the Exergame Enjoyment Questionnaire (EEQ) into Turkish will be carried out following the forward-backward translation method proposed by Beaton et al. (2000), which has international validity. In this context, the scale will first be translated from English to Turkish by two independent translators, one a healthcare specialist and the other a professional language expert. These two translations will then be compared to create a common preliminary text; subsequently, this text will be translated back into English by two independent translators whose native language is English and who are familiar with the conceptual content, and any loss of meaning will be evaluated. The resulting Turkish draft will be reviewed by an expert panel for cultural appropriateness, linguistic clarity, and conceptual equivalent; necessary adjustments will be made. Finally, the scale will be piloted on 10 elderly individuals selected from the target population, and feedback on the com

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Exergame Enjoyment Questionnaire (EEQ)
Zeitfenster: 2 weeks

The Exergame Enjoyment Questionnaire (EEQ) is a self-report, multidimensional measurement tool developed to assess the level of enjoyment individuals experience while participating in exercise-based digital games (Fitzgerald et al.). The scale allows for a comprehensive assessment of both the structural characteristics of the digital game and the experience related to physical activity (Fitzgerald et al.). The original form of the EEQ consists of a total of 20 items, adapted from scales such as the Game Engagement Questionnaire (GEQ), Immersive Experience Questionnaire (IEQ), and Physical Activity Enjoyment Scale (PACES), which have previously proven their validity and reliability (Fitzgerald et al.).

Each item is answered using a 5-point Likert scale ranging from 1 (Strongly Disagree) to 5 (Strongly Agree). The scale items are structured in four sub-dimensions: Immersion, Intrinsically Rewarding Activity, User Control, and Exercise Experience. O

2 weeks

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Physical Activity Enjoyment Scale (PAES)
Zeitfenster: 1 weeks
The Physical Activity Enjoyment Scale (PAES) is a self-report psychometric scale developed to assess the level of enjoyment individuals experience while participating in physical activity (Mullen et al., 2011; Özkurt et al., 2022). The Turkish adapted version of the scale was introduced to the Turkish population by Özkurt et al. (2022) after completing the cultural adaptation process and validity and reliability analyses. PAES has a single-factor structure consisting of 8 items. Each item is answered with a 7-point Likert scale ranging from 1 (Strongly Disagree) to 7 (Strongly Agree) (Özkurt et al., 2022). High scores obtained from the scale indicate that the individual experiences a high level of enjoyment during physical activity. The scale's internal consistency coefficient (Cronbach's alpha = 0.96) and composite reliability value (CR = 0.95) were found to be high, indicating that the scale has strong psychometric properties (Özkurt et al.,
1 weeks

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Publikationen und hilfreiche Links

Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.

Allgemeine Veröffentlichungen

  • Özkurt, B., Küçükibiş, H. F., & Eskiler, E. (2022). Fiziksel Aktivitelerden Keyif Alma Ölçeği (FAKÖ): Türk Kültürüne Uyarlama, Geçerlik ve Güvenirlik Çalışması. Anemon Muş Alparslan Üniversitesi Sosyal Bilimler Dergisi, 10(1), 21-37. https://doi.org/10.18506/anemon.976300
  • Fitzgerald, A., Huang, S., Sposato, K., Wang, D., Claypool, M., & Agu, E. (2020). The Exergame Enjoyment Questionnaire (EEQ): An instrument for measuring exergame enjoyment. Proceedings of the Hawaii International Conference on System Sciences (HICSS).

Nützliche Links

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Geschätzt)

30. April 2026

Primärer Abschluss (Geschätzt)

15. Mai 2026

Studienabschluss (Geschätzt)

30. September 2026

Studienanmeldedaten

Zuerst eingereicht

25. April 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

25. April 2026

Zuerst gepostet (Tatsächlich)

1. Mai 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

1. Mai 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

25. April 2026

Zuletzt verifiziert

1. April 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Zusätzliche relevante MeSH-Bedingungen

Andere Studien-ID-Nummern

  • 2026/45

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

NEIN

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Klinische Studien zur Validity and reliability assessments

Abonnieren